Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
I-Mab Announces Authorization of a Renewed Stock Repurchase Program by the Company up to US$40 Million 2021-07-29 20:00
MGI Australia Demo Lab Opens to Support APAC Customers 2021-07-29 19:18
HanAll Biopharma Reports Second Quarter 2021 Results 2021-07-29 18:44
Everest Medicines Receives Pediatric and Rare Severe Disease Priority Review Designation from Taiwan FDA for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer 2021-07-29 18:41
Daewoong Pharmaceutical Announces Camostat Achieving 50% Faster Recovery Time for Mild COVID-19 Patients Over Age of 50 in Topline Results from Phase 2B Clinical Trial 2021-07-29 18:00
Exyte Empowers the Biopharmaceutical Industry: First ExyCell(R) Facility Launched in Shanghai 2021-07-29 16:25
Ping An-Shionogi Joint Venture Launched in Shanghai, Expanding Footprint in Healthcare Industry 2021-07-29 15:45
Transcenta Announces Orphan Drug Designation Granted to TST001 for Treatment of Gastric and Gastroesophageal Junction 2021-07-29 07:46
Ascentage Pharma Announces Another Milestone Payment from Its Licensee UNITY Biotechnology, Rapidly Advancing the Clinical Development of Senolytic Drug Candidate UBX1325 2021-07-29 07:40
Margaret Crotty to lead JSI and World Education family of global agencies 2021-07-29 02:43
Are Textbooks Holding Back Cures for Cancer? 2021-07-29 02:40
Hemanext Partners with Sickle Cell 101 to Sponsor Sickle Cell Education 2021-07-28 23:43
Clarity commences Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial 2021-07-28 21:08
Leaf Space Applies Satellite Solutions to Enhance Connectivity for Home Monitoring of COVID-19 Patients with CARES Monitoring System 2021-07-28 21:00
Sasakawa Leprosy (Hansen's Disease) Initiative: "Don't Forget Leprosy" 2021-07-28 21:00
Fortacin™ Receives Extremely Encouraging Assessment in US Market Research Analysis 2021-07-28 20:05
United Imaging Goes "All-in" for Nashville 2021-07-28 20:00
GenScript Announces Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Kit 2021-07-28 19:30
I-Mab Announces IND Acceptance for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China 2021-07-28 19:15
BIOTRONIK Applauded by Frost & Sullivan for Its Disruptive Implantable Cardiac Monitoring Device, BIOMONITOR IIIm 2021-07-28 18:00
1 540 541 542 543 544 1567